881 studies found for:    "Sexually Transmitted Diseases, Viral"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Completed Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
Conditions: HIV Infection;   HIV Infections
Intervention: Behavioral: Adherence report
5 Completed A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects
Condition: Human Immunodeficiency Virus
Intervention: Drug: P2G12
6 Active, not recruiting
Has Results
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg twice daily;   Drug: dolutegravir placebo twice daily;   Drug: Open-label dolutegravir 50mg twice daily
7 Recruiting Cause of Focal Segmental Glomerulosclerosis
Conditions: AIDS Associated Nephropathy;   Focal Glomerulosclerosis;   HIV Infections
Intervention:
8 Not yet recruiting Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: EFV 600 mg
9 Terminated Safety and Tolerability of Z-100 in Patients With Early HIV Infection
Condition: HIV Infections
Intervention: Drug: Z-100
10 Completed A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
Conditions: Pneumonia, Pneumocystis Carinii;   HIV Infections
Intervention: Drug: Pentamidine isethionate
11 Completed A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
Conditions: HIV Infections;   Histoplasmosis
Intervention: Drug: Itraconazole
12 Not yet recruiting The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
Conditions: Human Immunodeficiency Virus (HIV);   Cardiovascular Disease (CVD)
Intervention: Drug: Rosuvastatin
13 Completed A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
Condition: HIV Infections
Intervention: Drug: Cimetidine
14 Completed Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
Condition: HIV Infections
Intervention: Drug: Butyldeoxynojirimycin
15 Recruiting Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study
Condition: Acquired Immune Deficiency Syndrome Virus
Intervention: Biological: Live attenuated Vaccine- Fluenz Tretra
16 Completed Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients
Condition: Human Immunodeficiency Virus
Intervention: Procedure: leukapheresis
17 Active, not recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
18 Recruiting Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
Conditions: Opiate Dependence;   Human Immunodeficiency Virus
Interventions: Drug: injectable naltrexone;   Drug: placebo comparator
19 Completed Efficacy of HIV Post-Test Support for ANC in South Africa
Conditions: HIV;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Enhanced Counseling;   Behavioral: Standard of Care
20 Completed Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection
Condition: HIV Infections
Interventions: Biological: MRKAd5 HIV-1 gag/pol/nef;   Biological: MRKAd5 HIV-1 gag/pol/nef placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years